Florida must address the insurance cost challenge. Mitigation is the state’s most proven, cost-effective and underutilized ...

The U.S. Food and Drug Administration said on Friday it had eliminated risk evaluation and mitigation strategies (REMS), a ...

Co-authors reported grants from Takeda Pharmaceuticals and UCB, consulting for GlaxoSmithKline, and personal fees from the ...

Manufacturing companies face escalating cyber risks as modernization—deploying generative AI; integrating information ...

Amid growing concerns about shark bites on Australian beaches, researchers have developed a new framework to compare and ...

The federal government has launched the Wildfire Resilience Consortium of Canada (WRCC), a new national initiative aimed at ...

The FDA has removed the REMS program requirements for embryofetal toxicity risk from all endothelin receptor antagonist medications.

Collaboration helps security and risk leaders communicate effectiveness of security investments and may help improve cyber insurance coverage termsSAN FRANCISCO, July 14, 2025 (GLOBE NEWSWIRE) -- ...

Pregnancies in patients on isotretinoin are lower than those on topical retinoids but still occur, despite the iPLEDGE program, and sociodemographic factors may play a role.

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories.

The FDA's ODAC voted that the benefit-risk profile of belantamab mafodotin in multiple myeloma were not favorable, ...

Seattle City Light underwent a shift to data-driven utility vegetation management to manage risks and improve reliability.